Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

Yang Y. Ding; Julie W. Stern; Tracey F. Jubelirer; Gerald B. Wertheim; Fumin Lin; Fengqi Chang; Zhaohui Gu; Charles G. Mullighan; Yong Li; Richard C. Harvey; I. Ming Chen; Cheryl L. Willman; Stephen P. Hunger; Marilyn M. Li; Sarah K. Tasian

doi:10.3324/haematol.2018.192088

Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

Yang Y. Ding, Julie W. Stern, Tracey F. Jubelirer, Gerald B. Wertheim, Fumin Lin, Fengqi Chang, Zhaohui Gu, Charles G. Mullighan, Yong Li, Richard C. Harvey, I. Ming Chen, Cheryl L. Willman, Stephen P. Hunger, Marilyn M. Li, Sarah K. Tasian

Laboratory Medicine and Pathology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	e427-e431
Journal	Haematologica
Volume	103
Issue number	9
DOIs	https://doi.org/10.3324/haematol.2018.192088
State	Published - Aug 31 2018

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2018.192088

Cite this

Ding, Y. Y., Stern, J. W., Jubelirer, T. F., Wertheim, G. B., Lin, F., Chang, F., Gu, Z., Mullighan, C. G., Li, Y., Harvey, R. C., Chen, I. M., Willman, C. L., Hunger, S. P., Li, M. M., & Tasian, S. K. (2018). Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure. Haematologica, 103(9), e427-e431. https://doi.org/10.3324/haematol.2018.192088

Ding, YY, Stern, JW, Jubelirer, TF, Wertheim, GB, Lin, F, Chang, F, Gu, Z, Mullighan, CG, Li, Y, Harvey, RC, Chen, IM, Willman, CL, Hunger, SP, Li, MM & Tasian, SK 2018, 'Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure', Haematologica, vol. 103, no. 9, pp. e427-e431. https://doi.org/10.3324/haematol.2018.192088

@article{f3fbf55bc6cd45d79773ce4c50ec0560,

title = "Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure",

author = "Ding, {Yang Y.} and Stern, {Julie W.} and Jubelirer, {Tracey F.} and Wertheim, {Gerald B.} and Fumin Lin and Fengqi Chang and Zhaohui Gu and Mullighan, {Charles G.} and Yong Li and Harvey, {Richard C.} and Chen, {I. Ming} and Willman, {Cheryl L.} and Hunger, {Stephen P.} and Li, {Marilyn M.} and Tasian, {Sarah K.}",

note = "Funding Information: Funding: these studies were supported by the National Institutes of Health/National Child Health and Human Development award T32HD043021 (YYD), National Cancer Institute K08CA184418 award (SKT), and the Rally Foundation for Childhood Cancer Research (SKT). CGM is the William E Evans Endowed Chair in Pathology. CLW is the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Professor of Pathology and Medicine. SPH is the Jeffrey E Perelman Distinguished Chair in Pediatrics at The Children's Hospital of Philadelphia. Correspondence: tasians@email.chop.edu doi:10.3324/haematol.2018.192088 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Funding Information: These studies were supported by the National Institutes of Health/National Child Health and Human Development award T32HD043021 (YYD), National Cancer Institute K08CA184418 award (SKT), and the Rally Foundation for Childhood Cancer Research (SKT). CGM is the William E Evans Endowed Chair in Pathology. CLW is the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Professor of Pathology and Medicine. SPH is the Jeffrey E Perelman Distinguished Chair in Pediatrics at The Children's Hospital of Philadelphia.",

year = "2018",

month = aug,

day = "31",

doi = "10.3324/haematol.2018.192088",

language = "English (US)",

volume = "103",

pages = "e427--e431",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "9",

}

TY - JOUR

T1 - Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

AU - Ding, Yang Y.

AU - Stern, Julie W.

AU - Jubelirer, Tracey F.

AU - Wertheim, Gerald B.

AU - Lin, Fumin

AU - Chang, Fengqi

AU - Gu, Zhaohui

AU - Mullighan, Charles G.

AU - Li, Yong

AU - Harvey, Richard C.

AU - Chen, I. Ming

AU - Willman, Cheryl L.

AU - Hunger, Stephen P.

AU - Li, Marilyn M.

AU - Tasian, Sarah K.

N1 - Funding Information: Funding: these studies were supported by the National Institutes of Health/National Child Health and Human Development award T32HD043021 (YYD), National Cancer Institute K08CA184418 award (SKT), and the Rally Foundation for Childhood Cancer Research (SKT). CGM is the William E Evans Endowed Chair in Pathology. CLW is the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Professor of Pathology and Medicine. SPH is the Jeffrey E Perelman Distinguished Chair in Pediatrics at The Children's Hospital of Philadelphia. Correspondence: tasians@email.chop.edu doi:10.3324/haematol.2018.192088 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org. Funding Information: These studies were supported by the National Institutes of Health/National Child Health and Human Development award T32HD043021 (YYD), National Cancer Institute K08CA184418 award (SKT), and the Rally Foundation for Childhood Cancer Research (SKT). CGM is the William E Evans Endowed Chair in Pathology. CLW is the Maurice and Marguerite Liberman Distinguished Chair in Cancer Research Professor of Pathology and Medicine. SPH is the Jeffrey E Perelman Distinguished Chair in Pediatrics at The Children's Hospital of Philadelphia.

PY - 2018/8/31

Y1 - 2018/8/31

UR - http://www.scopus.com/inward/record.url?scp=85052859795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052859795&partnerID=8YFLogxK

U2 - 10.3324/haematol.2018.192088

DO - 10.3324/haematol.2018.192088

M3 - Article

C2 - 29773603

AN - SCOPUS:85052859795

SN - 0390-6078

VL - 103

SP - e427-e431

JO - Haematologica

JF - Haematologica

IS - 9

ER -

Clinical efficacy of ruxolitinib and chemotherapy in a child with philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this